Pilot Study of a Brief, Recovery-focused Intervention for Crisis Stabilization Centers (THRIVE)
THRIVE: Pilot Study of a Brief, Recovery-focused Intervention for Crisis Stabilization Centers
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Jennifer D Lockman, PhD
- Phone Number: 615-830-2413
- Email: Jennifer.Lockman@Centerstone.org
Study Contact Backup
- Name: Anthony R Pisani, PhD
- Phone Number: (585) 275-3644
- Email: Anthony_Pisani@urmc.rochester.edu
Study Locations
-
-
Tennessee
-
Nashville, Tennessee, United States, 37228
- Mental Health Cooperative
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Admitted to the crisis stabilization center (CSC)
- Davidson county resident
- English-speaking
- Able to provide informed consent
- Willing to complete a locator form for follow-up assessments
- Willing to complete two emergency contacts
- Medically and clinically cleared by onsite psychiatrist/nurse practitioner
- Increased risk for suicide (Patient safety screener-3, Item 2 and/or 3 is "Yes")
- Willing and able to discuss their experiences around suicidal thoughts and/or attempts
Exclusion Criteria:
- Individuals who are acutely psychotic
- Individuals unable to communicate with the research team
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Experimental: THRIVE + Usual Care
Individuals presenting to a community-based crisis stabilization center who are age 18-plus and screen positive for suicide risk
|
Toward Hope, Recovery, Interpersonal Relationships, Values and Engagement (THRIVE), is a brief, suicide-specific, narrative, recovery-focused, 60 minute intervention.
THRIVE includes three components: 1) Sharing the suicide narrative; 2) Completing the Lifeline and Meaning Reconstruction; 3) Completing the Meaningful Living Plan (MLP).
Care as Usual in this Crisis Stabilization Unit includes medication management, medication management, safety planning Intervention, group psychoeducation, discharge planning, and community linkages
|
|
Active Comparator: Usual Care
Individuals presenting to a community-based crisis stabilization center who are age 18-plus and screen positive for suicide risk
|
Care as Usual in this Crisis Stabilization Unit includes medication management, medication management, safety planning Intervention, group psychoeducation, discharge planning, and community linkages
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Meaning made of stress
Time Frame: 3 months
|
Integration of Stressful Life Experiences Scale (ISLES; Holland et al., 2010).
Subscale scores range from 11 to 55 (Footing in the World subscale), 5 to 25 (Comprehensibility subscale) and 16 to 80 (Total ISLES score).
Higher scores on each ISLES subscale and the ISLES total score represent greater meaning reconstruction.
|
3 months
|
|
Hopefulness
Time Frame: 3 months
|
Adult State Hope Scale (ASHS; Snyder et al., 1996).
Subscale scores range from 3 to 34 (Pathways subscale), from 3 to 24 (Agency subscale), and from 6 to 48 (Total Hope Score).
Higher scores on each ASHS subscale and the ASHS total score represent higher levels of hope.
|
3 months
|
|
Self-efficacy to avoid suicidal action
Time Frame: 3 months
|
Self-Efficacy to Avoid Suicidal Action Scale (SEASA; Czyz et al., 2014).
The total score on the SEASA ranges from 0 to 54, with higher levels presenting higher self-efficacy to avoid suicidal action.
|
3 months
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Jennifer Lockman, PhD, Centerstone Research Institute
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- CenterstoneRI
- YIG-0-113-20 (Other Grant/Funding Number: American Foundation for Suicide Prevention)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.